Cargando…
Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant neoplasms worldwide. Although marker genes associated with CRC have been identified previously, only a few have fulfilled the therapeutic demand. Therefore, based on differentially expressed genes (DEGs), this study aimed to est...
Autores principales: | Wang, Di, Liufu, Junye, Yang, Qiyuan, Dai, Shengqun, Wang, Jiaqi, Xie, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628086/ https://www.ncbi.nlm.nih.gov/pubmed/36319976 http://dx.doi.org/10.1186/s13062-022-00342-w |
Ejemplares similares
-
Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022) -
Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers
por: Ghatak, Souvik, et al.
Publicado: (2022) -
Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021) -
Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
por: Wang, Jihan, et al.
Publicado: (2021) -
Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluation
por: Dai, Meiyu, et al.
Publicado: (2017)